Neonatal Outcomes after Uterus Transplantation: Dallas Uterus Transplant Study.


Journal

American journal of perinatology
ISSN: 1098-8785
Titre abrégé: Am J Perinatol
Pays: United States
ID NLM: 8405212

Informations de publication

Date de publication:
01 2023
Historique:
pubmed: 21 4 2021
medline: 22 12 2022
entrez: 20 4 2021
Statut: ppublish

Résumé

Limited data are available on the outcome of infants born after uterus transplantation. Our aim was to describe the hospital course and laboratory findings in the first 2 months of life of the 12 infants born in the Dallas UtErus Transplant Study (DUETS). Based on the trial protocol, information about infants was collected in a prospective fashion, including infant demographics, hospital course, and laboratory values. Twelve infants were delivered, all by cesarean section, from 11 mothers who had undergone uterus transplantation (one mother had two pregnancies and delivered two babies). All pregnancies were singleton. The mothers received immunosuppressive therapy, and one had a rejection episode that was detected during pregnancy. The rejection episode resolved after steroid treatment. The infants had a median gestational age of 36 The 12 infants born from mothers with uterus transplants had a neonatal course that reflected the gestational age at delivery. No baby was born with an identified malformation or organ dysfunction. Longer follow-up and a larger number of infants are needed to confirm these observations. · Normal fetal development after uterus transplantation.. · No baby was born with malformations or showed any organ dysfunction.. · At 2 months, all infants achieved appropriate developmental and behavioral milestones..

Identifiants

pubmed: 33878776
doi: 10.1055/s-0041-1727212
doi:

Banques de données

ClinicalTrials.gov
['NCT02656550']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

42-50

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Jackie R York (JR)

Department of Neonatology, Baylor University Medical Center, Dallas, Texas.

Giuliano Testa (G)

Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, Texas.

Robert T Gunby (RT)

Department of Obstetrics and Gynecology, Baylor University Medical Center, Dallas, Texas.

J Michael Putman (JM)

Fertility Center of Dallas, Baylor University Medical Center, Dallas, Texas.

Gregory J McKenna (GJ)

Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, Texas.

Eric C Koon (EC)

Department of Obstetrics and Gynecology, Baylor University Medical Center, Dallas, Texas.

Johanna Bayer (J)

Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, Texas.

Lilly Zhang (L)

Fertility Center of Dallas, Baylor University Medical Center, Dallas, Texas.

Anthony R Gregg (AR)

Department of Obstetrics and Gynecology, Baylor University Medical Center, Dallas, Texas.
Department of Obstetrics and Gynecology, PRISMA Health-University of South Carolina School of Medicine, Columbia, South Carolina.

Liza Johannesson (L)

Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, Texas.
Department of Obstetrics and Gynecology, Baylor University Medical Center, Dallas, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH